Join Genomind and guest speaker, Dr. Brian Miller MD, PhD, MPH, to explore the Cannabis Conundrum, and the Role of Cannabis Use in Persons with Psychotic Disorders.
Dr. Miller’s current research focuses on inflammation and immune dysfunction, as well as insomnia and suicide in schizophrenia, and has been funded by the National Institute of Mental Health, the Stanley Medical Research Foundation, and the Brain & Behavior Research Foundation. He has over 100 peer-reviewed publications. He has been recognized with several awards, including the 2011 Exemplary Psychiatrist Award from the National Alliance on Mental Illness, the 2015 Augusta University Outstanding Young Clinical Science Faculty Award, the 2017 OSU College of Medicine Early Career Achievement Alumni Award, and a 2020 Distinguished Fellow of the American Psychiatric Association. He has been an editorial board member of Biomarkers in Neuropsychiatry, BMC Psychiatry, Current Psychiatry, Schizophrenia Bulletin, and Psychiatric Times. In addition to his research, Dr. Miller provides clinical care for patients with schizophrenia, and supervises and teaches residents and medical students in general psychiatry.
In this 1-hour session, Dr. Miller will lead a 45-minute presentation, then conclude with a 15-minute Q&A session. For those unable to attend, a recording of the event will be sent to all registrants on a later date.
Dr. Brian Miller is a professor with tenure in the Department of Psychiatry and Health Behavior at Augusta University. He earned a BS in mathematics from Vanderbilt University, a combined MD/MPH degree from The Ohio State University, and a PhD in psychiatric epidemiology from the University of Oulu (Finland). He completed his general psychiatry residency and fellowship in psychotic disorders at Augusta University, where he served as chief resident, and joined the faculty in 2010.
